Costo-efectividad de dos terapias antivirales para hepatitis B crónica en el perú: Entecavir y tenofovir

Translated title of the contribution: Cost-effectiveness of two antiviral therapies for chronic hepatitis B in Peru: Entecavir and tenofovir

Rafael Bolaños-Díaz, Romina A. Tejada, César Sanabria, Seimer Escobedo-Palza

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Cost-effectiveness of two antiviral therapies for chronic hepatitis B in Peru: Entecavir and tenofovir'. Together they form a unique fingerprint.

Medicine & Life Sciences

Social Sciences